CRUK / Start Codon Entrepreneurial Training webinar: Making IP Count

26 August 2020, 12.00 PM - 26 August 2020, 1.30 PM

Tim Russell and Anton Hutter

online

Learn how to start your entrepreneurial journey from academia to industry and through to the board room.

Start Codon and Cancer Research UK are launching a series of free, online seminars to support and develop an entrepreneurial culture among cancer researchers in the UK.

The series is part of Start Codon and Cancer Research UK’s Entrepreneurial Training Scheme, which aims to promote the development of new business ventures within academia and encourage entrepreneurship. This three-part series is open to anyone working in oncology research, with any level of knowledge or experience in entrepreneurship. You do not need to have Cancer Research UK funding to join.

The seminars will be hosted on Microsoft Teams.

Intellectual property (patents, trademarks and designs) is a key component of an oncology company’s success but devising an IP strategy can be challenging. This seminar aims to help you understand, with case studies, what a start-up needs to consider, e.g. what is protectable and what is not; what should be protected and what should be kept secret; how to protect what differentiates you from your competitors; analysis of your competitors’ IP.

Register for your free ticket here

Tim Russell MSci CPA EPA, based in Venner Shipley’s Cambridge office, is a UK and European patent attorney in the chemical & life sciences team and has a background in the pharmaceutical industry. His expertise covers active pharmaceutical ingredients, small active molecules, formulations containing the same and medical uses as well as other chemical and biotech areas. As well as drafting, filing and prosecuting patent applications, Tim also has considerable experience in EPO oppositions and appeals, and advising clients on patent infringement and validity, freedom-to-operate clearances of third party patents, and providing due diligence opinions. Tim also works with SME’s to help devise their IP strategy. Specialising in the pharmaceutical sector, Tim works with a number of small and medium sized pharmaceutical/biotech companies as well as advising multinationals on their patent portfolios. He has also helped companies raise funds at different stages of their life cycle. His experience enables him to help companies maximise their IP, improve their processes, and highlight potential issues before they grow (as well as pinpoint how to fix them).Tim graduated from Bristol University with an MSci in Chemistry. During his graduate degree Tim spent 12 months working full-time as a medicinal chemist in the research laboratories of a multinational pharmaceutical company developing and synthesising potential active ingredients.

Anton Hutter BSc MSc PhD CPA EPA, is a UK & European patent attorney in the chemical & life sciences team founded and heads up the Venner Shipley's Guildford office. A significant proportion of Anton’s career has involved meeting world-class academics directly, and drafting and filing 100’s of patent applications in the bioscience and pharma sectors. Anton has drafted cases in a wide range of biotech areas, including the development and uses of various RNA and DNA vaccines (e.g. for preventing C. difficile and Bacillus spp. and turboculosis infections), virology and bacteriophage-based inventions, immunology and antibody-based technologies, genomics and proteomics, biomarkers for diagnosing disease, including the uses of single nucleotide polymorphisms (SNP’s), microRNAs and proteins for detecting a wide variety of conditions (e.g. microbial infections, cancer, Alzheimer’s disease, cardiovascular disease etc.), peptide and peptoid therapeutics, small molecule pharmaceuticals, medicine and chemical engineering. As well as drafting, filing and prosecuting patent applications, Anton also has considerable experience in EPO oppositions and appeals, and advising clients on patent infringement and validity, freedom-to-operate clearances of third party patents, and providing due diligence opinions. Anton holds a BSc in Biochemistry and Genetics, an MSc in Bioreactor Systems and Chemical Engineering, a PhD in Genetic Engineering, and a Certificate in Bioinformatics.

Contact information

Contact the organiser via the registration page

Edit this page